Home > Income Statement > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Revenue

    Back to Income Statement
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹241 Cr₹336 Cr₹279 Cr₹231 Cr₹46 Cr

What is the latest Revenue of BALAXI PHARMACEUTICALS ?

The latest Revenue ratio of BALAXI PHARMACEUTICALS is ₹241 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹241 Cr
Mar2024₹336 Cr
Mar2023₹279 Cr
Mar2022₹231 Cr
Mar2021₹46 Cr

How is Revenue of BALAXI PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2025 ₹241 Cr
-28.28
Mar2024 ₹336 Cr
20.42
Mar2023 ₹279 Cr
20.77
Mar2022 ₹231 Cr
406.94
Mar2021 ₹46 Cr -

Compare Revenue of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹149.4 Cr -0.4% -20.4% -62.6% Stock Analytics
ADANI ENTERPRISES ₹294,796.0 Cr 1.2% 0.8% -10.9% Stock Analytics
REDINGTON ₹21,600.4 Cr 1.4% -1.9% 44.2% Stock Analytics
MMTC ₹10,095.0 Cr 2.4% 10.8% -6.2% Stock Analytics
LLOYDS ENTERPRISES ₹9,568.4 Cr 0.2% 12.3% 37.2% Stock Analytics
HONASA CONSUMER ₹9,523.6 Cr 5.6% -0.7% 14.4% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-0.4%

-20.4%

-62.6%

SENSEX

-0.3%

-0.5%

8.3%


You may also like the below Video Courses